JAKARTA (Yosefardi) – Shares of pharmaceutical company PT Kalbe Farma Tbk (KLBF) Jumped 7.56% to Rp1,280 per share with 74 million shares exchanged hands in morning trade.
At this price, the company has market capitlization of Rp64.9 trillion. The stock had fallen 16% from its pick last month. Year to date, the stock gained 28%.
KLBF posted net profit of Rp454 billion in first quarter of 2013, grew by 10% from Rp412 billion in the same period of 2012. Revenues rose 16% to Rp3.49 trillion from previous Rp3.005 trillion.
The company will pay dividend of Rp891 billion, or Rp19 per share, for 2012 fiscal year, representing 51% of its 2012 net profit (Rp1.73 trillion). The dividend will be paid in July 2013.
The company allocates capital expenditure (capex) of Rp1 trillion to Rp1.5 trillion for this year, almost doubled from 2012’s capex. A half of capex will be used to fund the acquisition. KLBF targets revenue to grow by 16% to Rp3.4 trillion this year while net profit to grow by 10% to Rp444 billion.